Hochschulschrift
Cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
106 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Albert-Ludwigs-Universität Freiburg im Breisgau, Dissertation, 2025
- Klassifikation
-
Medizin, Gesundheit
- Schlagwort
-
Kuhpockenvirus
Zelltod
Makrophage
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg im Breisgau
- (wann)
-
[2025]
- Urheber
-
Klaas, Lioba (Verfasser)
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
- 17.02.2026, 12:12 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Klaas, Lioba (Verfasser)
Entstanden
- [2025]
Ähnliche Objekte (12)
Diversity of cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA)
Untersuchung von Modifiziertem Vaccinia Ankara Virus (MVA) zur Induktion Cytomegalovirus (CMV) spezifischer T-Zell-Antworten
Cell death and autophagy induction following modified vaccinia virus Ankara (MVA) infection give rise to efficient CTL priming
Recombinant modified Vaccinia Virus Ankara (MVA) vaccines efficiently protect cockatiels against parrot bornavirus infection and proventricular dilatation disease
Regulation of autophagy upon vaccinia virus infection
Immunogenität des Virus "MVA" (Modifiziertes Vaccinevirus Ankara)
A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA)
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Functional characterization of modified vaccinia virus Ankara-encoded anti-apoptotic proteins
OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial
Characterization of the avian designer cells AGE1.CR and AGE1.CR.plX considering growth, metabolism and production of influenza virus and Modified Vaccinia Virus Ankara (MVA)
Diversity of cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA)
Untersuchung von Modifiziertem Vaccinia Ankara Virus (MVA) zur Induktion Cytomegalovirus (CMV) spezifischer T-Zell-Antworten
Cell death and autophagy induction following modified vaccinia virus Ankara (MVA) infection give rise to efficient CTL priming
Recombinant modified Vaccinia Virus Ankara (MVA) vaccines efficiently protect cockatiels against parrot bornavirus infection and proventricular dilatation disease
Regulation of autophagy upon vaccinia virus infection
Immunogenität des Virus "MVA" (Modifiziertes Vaccinevirus Ankara)
A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA)
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Functional characterization of modified vaccinia virus Ankara-encoded anti-apoptotic proteins
OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial
Characterization of the avian designer cells AGE1.CR and AGE1.CR.plX considering growth, metabolism and production of influenza virus and Modified Vaccinia Virus Ankara (MVA)
Diversity of cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA)
Untersuchung von Modifiziertem Vaccinia Ankara Virus (MVA) zur Induktion Cytomegalovirus (CMV) spezifischer T-Zell-Antworten
Cell death and autophagy induction following modified vaccinia virus Ankara (MVA) infection give rise to efficient CTL priming
Recombinant modified Vaccinia Virus Ankara (MVA) vaccines efficiently protect cockatiels against parrot bornavirus infection and proventricular dilatation disease
Regulation of autophagy upon vaccinia virus infection
Immunogenität des Virus "MVA" (Modifiziertes Vaccinevirus Ankara)
A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA)
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Functional characterization of modified vaccinia virus Ankara-encoded anti-apoptotic proteins
OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial